Analyst Sees Relypsa's Valtassa Becoming 'The Standard Of Care,' Initiates With Buy, $63 Target
December 17, 2015 at 08:03 AM EST
Despite having recovered some of the losses over the last three months, Relypsa Inc (NASDAQ: RLYP) shares are down 8 percent ...